Literature DB >> 2327654

The nutritional status in advanced emphysema associated with chronic bronchitis. A study of amino acid and catecholamine levels.

J M Hofford1, L Milakofsky, W H Vogel, R S Sacher, G J Savage, S Pell.   

Abstract

Advanced emphysema with bronchitis is associated with significant weight loss and malnutrition, the true cause of which has not been clearly identified. The purpose of this exploratory study was to compare plasma amino acids and related compounds and catecholamines in a group of patients with advanced end-stage emphysema with a control group of similar age and sex in an effort to further understand this malnourished state. Fasting blood samples were obtained by venipuncture after a rest period. Plasma amino acid levels were determined by ion exchange high pressure liquid chromatography with fluorometric detection. Plasma catecholamines were determined by radioenzymatic analysis. Anthropometric measurements, the usually accepted biochemical markers of nutrition, dietary analysis, pulmonary function tests, and a historical analysis of the state of health including drug use and smoking history in each subject were analyzed. Ages and heights were comparable, whereas weights were significantly decreased in the patients with emphysema. Total serum protein and serum albumin values were significantly lower in the patient group. Significant respiratory muscle weakness was indicated by reduced negative inspiratory force in these end-stage patients, contrasting with well-preserved muscle strength usually found in obstructive lung disease. The dietary caloric intake of the patients was comparable to that of the control subjects. We conclude that the fine balance of the amino acid pool in patients with bronchitis and emphysema is well preserved, except for significant elevations of aspartic acid, glutamine, and cystine, and a decreased level of leucine. In addition, norepinephrine levels were significantly increased. Weight loss in patients with emphysema and bronchitis is likely due to increased energy demands related to hypermetabolism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2327654     DOI: 10.1164/ajrccm/141.4_Pt_1.902

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  17 in total

Review 1.  Can muscle protein metabolism be specifically targeted by nutritional support and exercise training in chronic obstructive pulmonary disease?

Authors:  Ramzi Lakhdar; Roberto A Rabinovich
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

2.  The carotid chemoreceptor contributes to the elevated arterial stiffness and vasoconstrictor outflow in chronic obstructive pulmonary disease.

Authors:  Devin B Phillips; Craig D Steinback; Sophie É Collins; Desi P Fuhr; Tracey L Bryan; Eric Y L Wong; Vincent Tedjasaputra; Mohit Bhutani; Michael K Stickland
Journal:  J Physiol       Date:  2018-04-11       Impact factor: 5.182

3.  Fat-free mass change after nutritional rehabilitation in weight losing COPD: role of insulin, C-reactive protein and tissue hypoxia.

Authors:  Simonetta Baldi; Roberto Aquilani; Gian Domenico Pinna; Paolo Poggi; Angelo De Martini; Claudio Bruschi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-02-18

4.  Increased sympathetic nerve activity in COPD is associated with morbidity and mortality.

Authors:  Stefan Andreas; Helge Haarmann; Stephan Klarner; Gerd Hasenfuss; Tobias Raupach
Journal:  Lung       Date:  2013-12-22       Impact factor: 2.584

Review 5.  Impact of nutritional status on body functioning in chronic obstructive pulmonary disease and how to intervene.

Authors:  Wahju Aniwidyaningsih; Raphaëlle Varraso; Noel Cano; Christophe Pison
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2008-07       Impact factor: 4.294

Review 6.  Role of specific dietary amino acids in clinical conditions.

Authors:  Renate Jonker; Mariëlle P K J Engelen; Nicolaas E P Deutz
Journal:  Br J Nutr       Date:  2012-08       Impact factor: 3.718

7.  Profiles of serum amino acids to screen for catabolic and inflammation status in calves with Mycoplasma bronchopneumonia.

Authors:  Kenji Tsukano; Kazuyuki Suzuki; Toshio Shimamori; Ayano Sato; Katsunori Kudo; Ryuji Asano; Tadaharu Ajito; Jeffrey Lakritz
Journal:  J Vet Med Sci       Date:  2014-10-22       Impact factor: 1.267

8.  Metabonomic profiling of serum and urine by (1)H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individuals.

Authors:  Lingling Wang; Yufu Tang; Shuo Liu; Shitao Mao; Yuan Ling; Dan Liu; Xiaoyu He; Xiaoge Wang
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

9.  Relationship between plasma l-lysine concentrations and levels of HIV-1 RNA.

Authors:  Evgeny Vlad Butorov
Journal:  Virulence       Date:  2013-09-17       Impact factor: 5.882

Review 10.  Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective.

Authors:  Karin J C Sanders; Anita E M Kneppers; Coby van de Bool; Ramon C J Langen; Annemie M W J Schols
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-09-07       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.